Patents by Inventor Heinrich Barchet

Heinrich Barchet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION THERAPY OF AN AFUCOSYLATED ANTIBODY AND ONE OR MORE OF THE CYTOKINES GM CSF, M CSF AND/OR IL3
    Publication number: 20100247484
    Abstract: The present invention is directed to the combination therapy of an afucosylated antibody specifically binding to a tumor-antigen with one or more cytokines selected from the group of human GM-CSF, human M-CSF and/or human IL-3 for the treatment of cancer.
    Type: Application
    Filed: March 29, 2010
    Publication date: September 30, 2010
    Inventors: HEINRICH BARCHET, GEORG FERTIG, CLAUDIA KIRSTENPFAD
  • Tumoricidal T lymphocytes
    Patent number: 6576466
    Abstract: The present invention concerns a mammalian cell line which when co-cultured with lymphocytes during which allogenic stimulation is avoided activates lymphocytes fo form tumoricidal cells, a process for the production of tumoricidal T lymphocytes by co-culturing lymphocytes with this cell line, the tumoricidal T lymphocytes obtained by means of this process and the use of the cells according to the present invention for the production of a therapeutic agent which can be used in tumour therapy.
    Type: Grant
    Filed: December 4, 1995
    Date of Patent: June 10, 2003
    Inventors: Herbert Jungfer, Heinrich Barchet, Winfred Albert, Ulrich Weidle
  • Process for producing and multiplying lymphocytes
    Patent number: 6511848
    Abstract: A method for culturing and/or multiplying lymphocytes in cell culture medium which contains as lymphocyte growth factor and additionally, aurin tricarboxylic acid, ciclosporin, tacrolimus, and/or ascomycin.
    Type: Grant
    Filed: November 12, 1998
    Date of Patent: January 28, 2003
    Assignee: Winfried Albert
    Inventors: Herbert Jungfer, Heinrich Barchet, Winfried Albert
  • PROCESS FOR PRODUCING AND MULTIPLYING LYMPHOCYTES
    Publication number: 20020055170
    Abstract: A process is disclosed for growing and/or multiplying lymphocytes in a cell culture medium which contains a lymphocyte growth factor, as well as aurintricarboxylic acid, cyclosporin and/or ascomycin. This process is particularly suitable to produce tumoricide killer T-cells.
    Type: Application
    Filed: November 12, 1998
    Publication date: May 9, 2002
    Inventors: HERBERT JUNGFER, HEINRICH BARCHET, WINFRIED ALBERT
  • TUMORICIDAL T LYMPHOCYTES
    Publication number: 20020039569
    Abstract: The present invention concerns a mammalian cell line which when co-cultured with lymphocytes during which allogenic stimulation is avoided activates lymphocytes fo form tumoricidal cells, a process for the production of tumoricidal T lymphocytes by co-culturing lymphocytes with this cell line, the tumoricidal T lymphocytes obtained by means of this process and the use of the cells according to the present invention for the production of a therapeutic agent which can be used in tumour therapy.
    Type: Application
    Filed: December 4, 1995
    Publication date: April 4, 2002
    Inventors: HERBERT JUNGFER, HEINRICH BARCHET, WINFRED ALBERT, ULRICH WEIDLE
  • Nucleic acid molecules which immortalize human or animal cells and uses thereof
    Patent number: 5674723
    Abstract: The present invention concerns DNA sequences which are suitable for immortalizing human or animal cells, processes for isolating such DNA sequences as well as processes for producing immortalized human or animal cells using such a DNA.
    Type: Grant
    Filed: February 2, 1995
    Date of Patent: October 7, 1997
    Assignee: Boehringer Mannheim GmbH
    Inventors: Hinrich Johann Abken, Klaus Willecke, Herbert Jungfer, Heinrich Barchet
  • Process for the production of permanently culturable animal and human cell lines and the use thereof
    Patent number: 5114847
    Abstract: A method for obtaining permanently culturable human and animal cell lines, as well as uses for these cell lines, are disclosed. The method involves fusing cells of a non-immortal cell line with cytoplasts or cytoplasma fractions of "immortal", transformed cells such as immortal myeloma cells, ascites-tumor cells or Epstein Barr Virus infected cells. Once fusion takes place the product is a permanently culturable variant of the previously normal cell line.
    Type: Grant
    Filed: September 25, 1990
    Date of Patent: May 19, 1992
    Assignee: Boehringer Mannheim GmbH
    Inventors: Herbert Jungfer, Heinrich Barchet, Winfried Albert